Sakaguchi S - Search Results

1

Intracellular tumor-associated antigens represent effective targets for passive immunotherapy.

Noguchi T, Kato T, Wang L, Maeda Y, Ikeda H, Sato E, Knuth A, Gnjatic S, Ritter G, Sakaguchi S, Old LJ, Shiku H, Nishikawa H. Noguchi T, et al. Among authors: sakaguchi s. Cancer Res. 2012 Apr 1;72(7):1672-82. doi: 10.1158/0008-5472.CAN-11-3072. Epub 2012 Feb 8. Cancer Res. 2012. PMID: 22318866 Free article.

2

Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.

Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, Nakayama E. Onizuka S, et al. Among authors: sakaguchi s. Cancer Res. 1999 Jul 1;59(13):3128-33. Cancer Res. 1999. PMID: 10397255

3

Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells.

Nishikawa H, Kato T, Tawara I, Saito K, Ikeda H, Kuribayashi K, Allen PM, Schreiber RD, Sakaguchi S, Old LJ, Shiku H. Nishikawa H, et al. Among authors: sakaguchi s. J Exp Med. 2005 Mar 7;201(5):681-6. doi: 10.1084/jem.20041959. J Exp Med. 2005. PMID: 15753203 Free PMC article.

4

Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity.

Cohen AD, Diab A, Perales MA, Wolchok JD, Rizzuto G, Merghoub T, Huggins D, Liu C, Turk MJ, Restifo NP, Sakaguchi S, Houghton AN. Cohen AD, et al. Among authors: sakaguchi s. Cancer Res. 2006 May 1;66(9):4904-12. doi: 10.1158/0008-5472.CAN-05-2813. Cancer Res. 2006. PMID: 16651447 Free PMC article.

5

A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model.

Ko HJ, Kim YJ, Kim YS, Chang WS, Ko SY, Chang SY, Sakaguchi S, Kang CY. Ko HJ, et al. Among authors: sakaguchi s. Cancer Res. 2007 Aug 1;67(15):7477-86. doi: 10.1158/0008-5472.CAN-06-4639. Cancer Res. 2007. PMID: 17671218

6

Systemic targeting of CpG-ODN to the tumor microenvironment with anti-neu-CpG hybrid molecule and T regulatory cell depletion induces memory responses in BALB-neuT tolerant mice.

Sharma S, Dominguez AL, Manrique SZ, Cavallo F, Sakaguchi S, Lustgarten J. Sharma S, et al. Among authors: sakaguchi s. Cancer Res. 2008 Sep 15;68(18):7530-40. doi: 10.1158/0008-5472.CAN-08-1635. Cancer Res. 2008. PMID: 18794141 Free PMC article.

7

Immune rejection of mouse tumors expressing mutated self.

Duan F, Lin Y, Liu C, Engelhorn ME, Cohen AD, Curran M, Sakaguchi S, Merghoub T, Terzulli S, Wolchok JD, Houghton AN. Duan F, et al. Among authors: sakaguchi s. Cancer Res. 2009 Apr 15;69(8):3545-53. doi: 10.1158/0008-5472.CAN-08-2779. Epub 2009 Apr 7. Cancer Res. 2009. PMID: 19351857 Free PMC article.

8

Multiple antitumor mechanisms downstream of prophylactic regulatory T-cell depletion.

Teng MW, Swann JB, von Scheidt B, Sharkey J, Zerafa N, McLaughlin N, Yamaguchi T, Sakaguchi S, Darcy PK, Smyth MJ. Teng MW, et al. Among authors: sakaguchi s. Cancer Res. 2010 Apr 1;70(7):2665-74. doi: 10.1158/0008-5472.CAN-09-1574. Epub 2010 Mar 23. Cancer Res. 2010. PMID: 20332236

9

Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals.

Mitsui J, Nishikawa H, Muraoka D, Wang L, Noguchi T, Sato E, Kondo S, Allison JP, Sakaguchi S, Old LJ, Kato T, Shiku H. Mitsui J, et al. Among authors: sakaguchi s. Clin Cancer Res. 2010 May 15;16(10):2781-91. doi: 10.1158/1078-0432.CCR-09-3243. Epub 2010 May 11. Clin Cancer Res. 2010. PMID: 20460483

10

Regulatory T cells in tumor immunity.

Nishikawa H, Sakaguchi S. Nishikawa H, et al. Among authors: sakaguchi s. Int J Cancer. 2010 Aug 15;127(4):759-67. doi: 10.1002/ijc.25429. Int J Cancer. 2010. PMID: 20518016 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,222 results

Search Page

Filters